Open-Label Phase 2 Trial of a Steroid-Free, CNI-Free, Belatacept-Based Immunosuppressive Regimen
Clinical trial NCT01856257 · TERMINATED
Trial details
- NCT number
- NCT01856257
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-01
- Primary completion
- 2016-04-01
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.